Quflora Pediatric NDC 15370-105

NDC codes

FDA NDC Directory

Product NDC (as listed)15370-105Labeler and product segments. Claims need a package NDC.

Product NDC at billing width15370-0105Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
15370-105-30	15370010530	30 TABLET, CHEWABLE in 1 BOTTLE (15370-105-30)Marketed from Jan 6, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Quflora Pediatric
Generic name (nonproprietary): vitamin a acetate, ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, thiamine hydrochloride, riboflavin, niacinamide, pyridoxine hydrochloride, levomefolic acid, folic acid, cyanocobalamin, magnesium oxide, cupric sulfate, and sodium fluoride
Active ingredients: Vitamin a acetate — 1200 [iU]/1Ascorbic acid — 60 mg/1Cholecalciferol — 400 [iU]/1.alpha.-tocopherol, Dl- — 15 [iU]/1Thiamine hydrochloride — 1.2 mg/1Riboflavin — 1.3 mg/1Niacinamide — 5 mg/1Pyridoxine hydrochloride — 1.5 mg/1Levomefolic acid — 108 ug/1Folic acid — 100 ug/1Cyanocobalamin — 4 ug/1Magnesium oxide — 15 mg/1Cupric sulfate — 1 mg/1Sodium fluoride — 1 mg/1
Dosage form: Tablet, Chewable
Route: Oral
Labeler: CarWin Pharmaceutical Associates, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jan 6, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Analogs/Derivatives (Chemical/Ingredient)Ascorbic Acid (Chemical structure)Folic Acid (Chemical structure)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)Vitamin A (Chemical structure)Vitamin B 12 (Chemical structure)Vitamin B 6 (Chemical/Ingredient)Vitamin D (Chemical structure)
Identifiers: Product ID 15370-105_0ad40f28-c81d-440a-8c07-d59f667487edSPL ID 0ad40f28-c81d-440a-8c07-d59f667487edSPL set ID b8e08798-d8bb-4616-996b-a2c07a5d730aUNII LRX7AJ16DT, 68Y4CF58BV, TLM2976OFR, 7QWA1RIO01, 25X51I8RD4, 8ZYQ1474W7, 935E97BOY8, 1C6V77QF41, 3A3U0GI71G, 3LE3D9D6OY, PQ6CK8PD0R, 8S95DH25XC, P6YC3EG204, M572600E5P
Pharmacologic class: Calculi Dissolution Agent; Folate Analog; Osmotic Laxative; Vitamin A; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N415370010530 followed by a unit qualifier and the quantity

Package 15370-0105-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 10, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Quflora™ Pediatric Chewable Tablets with 0.5 mg Fluoride is a prescription dietary fluoride supplement providing twelve essential vitamins and minerals.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)